Related Experiment Video

Updated: Sep 14, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.5K

A Multicenter Randomized Controlled Study on Pharmacokinetic-Guided Vancomycin Use in Children With Severe Infections

Fuxiang He1, Ya Yang2, Bo Zhou3

  • 1Department of Emergency Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.

Clinical and Translational Science
|July 24, 2025
PubMed

Insights

This study found that monitoring vancomycin trough concentration (Cmin) in children with severe infections may reduce pediatric intensive care unit (PICU) stays and mechanical ventilation times compared to using the area under the curve (AUC0-24/MIC) parameter.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacology
  • Pharmacokinetics/Pharmacodynamics

Background:

  • Vancomycin is crucial for treating severe pediatric infections.
  • Optimizing vancomycin dosing is essential for efficacy and safety.
  • Pharmacokinetic/pharmacodynamic (PK/PD) parameters guide vancomycin therapy.

Purpose of the Study:

  • To compare the clinical outcomes of vancomycin therapy guided by trough concentration (Cmin) versus area under the curve (AUC0-24/MIC) in children with severe infections.
  • To evaluate the impact of these PK/PD parameters on clinical efficacy, adverse reactions, and resource utilization.

Main Methods:

  • A multicenter, randomized controlled prospective trial involving 393 pediatric patients with severe infections.
  • Patients were randomized into either the Cmin group or the AUC0-24/MIC group.
  • PK/PD targets were Cmin (5-15 mg/L) and AUC0-24/MIC (400-600 mg·h/L).

Main Results:

  • No significant differences in daily dose, clinical efficacy, or adverse reactions between the groups.
  • The Cmin group showed significantly shorter pediatric intensive care unit (PICU) stays.
  • Patients aged 28 days to 1 year in the Cmin group had shorter mechanical ventilation durations.

Conclusions:

  • Both Cmin and AUC0-24/MIC are effective for guiding vancomycin treatment in children with severe infections.
  • Cmin-guided therapy demonstrated advantages in reducing PICU length of stay and mechanical ventilation duration.
  • Cmin monitoring may be a more beneficial strategy for optimizing vancomycin therapy in specific pediatric populations.

Keywords:
age groupsclinical efficacyinfectionspediatricspharmacokineticsvancomycin

More Related Videos

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.1K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.3K

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
141
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
717
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
126
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
41